Supernus Pharmaceuticals IncAdd to My Watchlist

SUPN:USNASDAQ GMIndustry: Medical-Drugs
  • 13.41
  • 0.06  -0.45%
    Today's Change
  • 13.47
    Previous Close
  • Today
    52 Week Low - High
8:10 pm ET 4/20/2015
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding47 million
Market Cap$627 million
Return on Equity ttm37.92%
Last DividendSUPN:US does not pay a dividend
EPS: Year Actual ttm0.443
EPS: Year Est. 12/15 ttm0.133
EPS: Quarterly Actual 12/14 0.08
EPS: Quarterly Est. 3/15 -0.01
Price/Earnings ttm30.26
Relative Price/Earnings1.632
Earnings Growth Rate--
Company Description
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company develops and markets proprietary drugs for the treatment of central nervous system diseases and disorders. Supernus has developed a portfolio of clinical stage drugs to address neurological and psychological problems such as epilepsy, conduct disorder, Parkinson's disease, ADHD, depression and anxiety.
Revenue$122 million
Net Income$20 million
Total Assets$138 million

Latest Headlines

No news available.


    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now


    Not Registered?

    Get complete access to The Washington Post online - it's FREE!